Yukinori Matsuo

19PUBLICATIONS
28CO-AUTHORS
Instruments and techniquesRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 16, 2026
Credentialing of small-field dosimetry for the lung SBRT in Japan Clinical Oncology Group clinical trial.

|Apr 14, 2026
Hypofractionated radiotherapy across cancer sites: a narrative review of evidence and implementation.

Masahiro Inada, Takuya Uehara, Yukinori Matsuo

|Jun 16, 2025
Prognostic Impact of Tumor Solid Components in Stereotactic Body Radiotherapy for Clinical Stage Tis-1N0M0 Lung Cancer.

Junki Fukuda, Hiroshi Doi, Atsushi Kono

|Feb 05, 2025
Multi-Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor-Tracking, Moderately Hypofractionated Intensity-Modulated Radiotherapy in Patients With Locally Advanced Pancreatic Cancer.

Michio Yoshimura, Masahiro Hiraoka, Masaki Kokubo

|Nov 07, 2024
Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study.

Hiroshi Doi, Yukinori Matsuo, Noriko Kishi

|Aug 28, 2024
Radiation-Induced Lymphopenia and Its Impact on Survival in Patients with Brain Metastasis.

Naoko Ishida, Yukinori Matsuo, Junki Fukuda

Pageof 4

Frequent Collaborators

5 joint publications

Hiroshi Onishi

5 joint publications

Takashi Mizowaki

3 joint publications

Noriko Kishi

2 joint publications

Yasuo Matsumoto